Cytomegalovirus (CMV)

CYTOMEGALOVIRUS (CMV) VACCINE STUDY
What is CMV?
Cytomegalovirus, shortened to CMV, is a leading cause of birth defects around the world. CMV is a common viral infection that usually goes unnoticed or only causes mild symptoms in most people. But if a woman becomes infected with CMV while she is pregnant, she can pass the infection to her unborn baby. This can cause her child to suffer long-term disability due to birth defects, including hearing loss, or even death in very severe cases. Currently, there is no approved vaccine against CMV.
Let us be the generation that stands up to cytomegalovirus (CMV), a highly contagious viral infection that can harm an unborn child. Learn more about a clinical trial for a potential vaccine.

To qualify, you must be:
- A female aged 16 or 17
- In generally good health
- In close contact with at least one child 5 years of age or younger for at least 8 hours a week, if age 20 or older
- Not pregnant or planning on becoming pregnant within the next 9 months
Qualified participants will receive:
- Study-related medication at no cost
- Study-related medical exams at no cost
- Compensation up to $1550 for time and travel


Why Participate?
Contribute to the advancement of medical knowledge and treatments, while receiving expert medical care under close supervision.

Experience
The M3 Wake Research Network has powered innovation with over 9,100 Successful Clinical Trials in patients from 6 months to 85 years.

Safety
Patient safety is paramount with strict protocols and ethical guidelines, minimizing risks and ensuring thorough monitoring throughout the trial.

Tucson Neuroscience Research
Study Hotline
+1-520-210-5092
Main Office
+1-520-225-0382
Our Hours
Mon-Fri: 9am-5pm
Our Address
6567 E. Carondelet Drive
Suite 455
Tucson, AZ 85710-2156